Related Experiment Video
Updated: Jan 9, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Rituximab-Based Management of Autoimmune Blistering Diseases: A Case Series Highlighting Ocular and Systemic
Sebastián J Vázquez-Folch1, Gabriel A Jiménez-Berríos1, Victor J Vazquez2
1School of Medicine, Universidad Central del Caribe, Bayamón, PRI.
Early diagnosis and treatment of autoimmune blistering diseases like mucous membrane pemphigoid (MMP) and pemphigus vulgaris (PV) are crucial. Rituximab offers effective, steroid-sparing remission, especially for vision-threatening ocular MMP.
Area of Science:
- Dermatology
- Autoimmunology
- Ophthalmology
Background:
- Mucous membrane pemphigoid (MMP), bullous pemphigoid (BP), and pemphigus vulgaris (PV) are rare autoimmune blistering disorders.
- These conditions often lead to delayed diagnosis and significant morbidity, affecting skin and mucous membranes.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Nephrotic Syndrome II : Assessment and Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rheumatic Heart Disease III: Medical Management

